SIMILAR PATTERNS OF AMINO ACIDS FOR 6F3N_B_ADNB505_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1aua | PHOSPHATIDYLINOSITOLTRANSFER PROTEINSEC14P (Saccharomycescerevisiae) |
PF00650(CRAL_TRIO)PF03765(CRAL_TRIO_N) | 5 | THR A 25ASP A 20LYS A 116ASP A 117LEU A 22 | None | 1.26A | 6f3nB-1auaA:undetectable | 6f3nB-1auaA:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gq7 | PROCLAVAMINATEAMIDINO HYDROLASE (Streptomycesclavuligerus) |
PF00491(Arginase) | 5 | HIS A 146ASP A 237THR A 247GLY A 161HIS A 160 | MN A 351 (-3.3A) MN A 351 (-2.2A)NoneNoneNone | 1.38A | 6f3nB-1gq7A:3.1 | 6f3nB-1gq7A:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1h2b | ALCOHOLDEHYDROGENASE (Aeropyrumpernix) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | HIS A 79ASP A 168THR A 172LEU A 131MET A 121 | ZN A1362 ( 3.2A) ZN A1362 (-2.7A)NAJ A1361 (-3.4A)OCA A1360 (-4.8A)None | 1.48A | 6f3nB-1h2bA:6.4 | 6f3nB-1h2bA:23.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1p8r | ARGINASE 1 (Rattusnorvegicus) |
PF00491(Arginase) | 5 | HIS A 126ASP A 234THR A 244GLY A 142HIS A 141 | MN A 500 ( 3.2A) MN A 500 ( 2.1A)NoneS2C A 551 ( 3.9A)S2C A 551 (-3.7A) | 1.45A | 6f3nB-1p8rA:2.2 | 6f3nB-1p8rA:21.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) |
PF00465(Fe-ADH) | 5 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.40A | 6f3nB-1rrmA:4.3 | 6f3nB-1rrmA:23.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uzg | MAJOR ENVELOPEPROTEIN E (Dengue virus) |
PF00869(Flavi_glycoprot)PF02832(Flavi_glycop_C) | 5 | THR A 313THR A 40ASP A 42LEU A 319PHE A 11 | None | 1.42A | 6f3nB-1uzgA:undetectable | 6f3nB-1uzgA:21.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 54ASP A 134GLU A 200LYS A 230ASP A 234LEU A 389HIS A 398 | ADN A 502 (-4.1A)ADN A 502 (-3.1A)ADN A 502 (-4.0A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)NAD A 501 ( 3.8A)ADN A 502 ( 3.5A) | 1.49A | 6f3nB-1v8bA:50.7 | 6f3nB-1v8bA:44.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 54THR A 56ASP A 134GLU A 200THR A 201LYS A 230ASP A 234LEU A 392GLY A 397HIS A 398MET A 403PHE A 407 | ADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-3.1A)ADN A 502 (-4.0A)NAD A 501 ( 2.8A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.7A)ADN A 502 ( 3.5A)ADN A 502 (-3.6A)None | 0.34A | 6f3nB-1v8bA:50.7 | 6f3nB-1v8bA:44.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b24 | NAPHTHALENEDIOXYGENASE LARGESUBUNIT (Rhodococcus sp.NCIMB 12038) |
PF00355(Rieske)PF00848(Ring_hydroxyl_A) | 5 | THR A 322THR A 217ASP A 372GLY A 363PHE A 210 | NoneIND A 503 ( 4.3A) FE A 502 (-2.1A)NoneIND A 503 ( 4.4A) | 1.29A | 6f3nB-2b24A:undetectable | 6f3nB-2b24A:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2o96 | 26S PROTEASOMENON-ATPASEREGULATORY SUBUNIT 7 (Homo sapiens) |
PF01398(JAB) | 5 | ASP A 65ASP A 105GLY A 98HIS A 96PHE A 58 | None | 1.49A | 6f3nB-2o96A:undetectable | 6f3nB-2o96A:15.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pqd | 3-PHOSPHOSHIKIMATE1-CARBOXYVINYLTRANSFERASE (Agrobacteriumsp.) |
PF00275(EPSP_synthase) | 5 | THR A 275ASP A 300GLU A 299LYS A 205ASP A 201 | None | 1.38A | 6f3nB-2pqdA:undetectable | 6f3nB-2pqdA:22.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pts | ADENYLOSUCCINATELYASE (Escherichiacoli) |
PF00206(Lyase_1)PF08328(ASL_C) | 5 | THR A 246ASP A 336THR A 338LYS A 327HIS A 251 | None | 1.44A | 6f3nB-2ptsA:undetectable | 6f3nB-2ptsA:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q09 | IMIDAZOLONEPROPIONASE (unidentified) |
PF01979(Amidohydro_1) | 5 | THR A 285GLU A 139ASP A 212LEU A 287HIS A 242 | NoneNoneNoneNone FE A 500 ( 3.5A) | 1.38A | 6f3nB-2q09A:4.0 | 6f3nB-2q09A:23.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wab | ENDOGLUCANASE E (Ruminiclostridiumthermocellum) |
PF00657(Lipase_GDSL) | 5 | HIS A 316THR A 315GLY A 306HIS A 310MET A 263 | NoneGOL A1341 (-3.7A)NoneBGC A1338 (-4.0A)BGC A1337 (-4.5A) | 1.32A | 6f3nB-2wabA:6.7 | 6f3nB-2wabA:19.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xsr | CATECHOL 1,2DIOXYGENASE (Acinetobacterradioresistens) |
PF00775(Dioxygenase_C)PF04444(Dioxygenase_N) | 5 | ASP A 246LEU A 207GLY A 214HIS A 213PHE A 250 | None | 1.34A | 6f3nB-2xsrA:undetectable | 6f3nB-2xsrA:21.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3azq | AMINOPEPTIDASE (Streptomycesmorookaense) |
PF00326(Peptidase_S9) | 5 | THR A 531ASP A 445LEU A 533GLY A 509PHE A 449 | None | 1.33A | 6f3nB-3azqA:4.5 | 6f3nB-3azqA:22.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 156GLU A 218THR A 219LYS A 248ASP A 252LEU A 407 | ADN A 500 (-2.9A)ADN A 500 (-2.6A)NAD A 550 ( 2.8A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)NAD A 550 (-4.2A) | 1.30A | 6f3nB-3ce6A:52.3 | 6f3nB-3ce6A:49.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 69THR A 71ASP A 156GLU A 218THR A 219LYS A 248ASP A 252LEU A 410GLY A 415HIS A 416MET A 421PHE A 425 | ADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-2.9A)ADN A 500 (-2.6A)NAD A 550 ( 2.8A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.52A | 6f3nB-3ce6A:52.3 | 6f3nB-3ce6A:49.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 69THR A 74ASP A 156THR A 219ASP A 252 | ADN A 500 (-4.0A)ADN A 500 (-4.5A)ADN A 500 (-2.9A)NAD A 550 ( 2.8A)ADN A 500 (-2.7A) | 1.30A | 6f3nB-3ce6A:52.3 | 6f3nB-3ce6A:49.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | HIS A 52THR A 54ASP A 130GLU A 155THR A 156LEU A 346GLY A 351HIS A 352MET A 357PHE A 361 | ADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-4.1A)ADN A 438 (-3.8A)NAD A 439 ( 3.0A)ADN A 438 ( 4.8A)ADN A 438 ( 3.8A)ADN A 438 ( 3.6A)ADN A 438 (-3.7A)None | 0.51A | 6f3nB-3g1uA:55.0 | 6f3nB-3g1uA:55.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gb0 | PEPTIDASE T (Bacillus cereus) |
PF01546(Peptidase_M20)PF07687(M20_dimer) | 5 | GLU A 141THR A 80ASP A 107LEU A 112GLY A 111 | None | 1.39A | 6f3nB-3gb0A:undetectable | 6f3nB-3gb0A:23.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 385HIS A 394 | RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.30A | 6f3nB-3glqA:54.1 | 6f3nB-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 62THR A 64ASP A 139GLU A 199THR A 200LYS A 229ASP A 233LEU A 388GLY A 393HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)NAD A 601 ( 2.9A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.37A | 6f3nB-3glqA:54.1 | 6f3nB-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 67ASP A 139THR A 200ASP A 233 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)NAD A 601 ( 2.9A)RAB A 602 (-2.5A) | 1.34A | 6f3nB-3glqA:54.1 | 6f3nB-3glqA:52.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 52ASP A 130GLU A 155LYS A 185ASP A 189LEU A 343HIS A 352 | ADN A 439 ( 4.7A)NoneNoneNAD A 438 ( 3.9A)NAD A 438 ( 4.4A)NAD A 438 (-4.0A)ADN A 439 ( 3.3A) | 1.42A | 6f3nB-3h9uA:56.8 | 6f3nB-3h9uA:55.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 52THR A 54ASP A 130GLU A 155THR A 156LYS A 185ASP A 189LEU A 346GLY A 351HIS A 352MET A 357PHE A 361 | ADN A 439 ( 4.7A)ADN A 439 (-2.7A)NoneNoneNAD A 438 (-3.8A)NAD A 438 ( 3.9A)NAD A 438 ( 4.4A)ADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.3A)ADN A 439 ( 3.7A)None | 0.28A | 6f3nB-3h9uA:56.8 | 6f3nB-3h9uA:55.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 52THR A 57ASP A 130THR A 156ASP A 189 | ADN A 439 ( 4.7A)ADN A 439 (-4.7A)NoneNAD A 438 (-3.8A)NAD A 438 ( 4.4A) | 1.39A | 6f3nB-3h9uA:56.8 | 6f3nB-3h9uA:55.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kjr | DIHYDROFOLATEREDUCTASE/THYMIDYLATE SYNTHASE (Babesia bovis) |
PF00186(DHFR_1)PF00303(Thymidylat_synt) | 5 | HIS A 459ASP A 458THR A 251LEU A 419GLY A 420 | None | 1.47A | 6f3nB-3kjrA:undetectable | 6f3nB-3kjrA:22.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | ASP A 132GLU A 192THR A 193LYS A 222ASP A 226LEU A 378HIS A 387 | ADN A 500 (-3.3A)ADN A 500 (-3.6A)NAD A 550 ( 3.0A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)NAD A 550 (-4.3A)ADN A 500 (-3.4A) | 1.28A | 6f3nB-3n58A:54.5 | 6f3nB-3n58A:52.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 55THR A 57ASP A 132GLU A 192THR A 193LYS A 222ASP A 226LEU A 381GLY A 386HIS A 387MET A 392PHE A 396 | ADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.3A)ADN A 500 (-3.6A)NAD A 550 ( 3.0A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.4A)ADN A 500 (-3.7A)None | 0.16A | 6f3nB-3n58A:54.5 | 6f3nB-3n58A:52.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 55THR A 60ASP A 132THR A 193ASP A 226 | ADN A 500 (-4.0A)ADN A 500 (-4.6A)ADN A 500 (-3.3A)NAD A 550 ( 3.0A)ADN A 500 ( 2.6A) | 1.27A | 6f3nB-3n58A:54.5 | 6f3nB-3n58A:52.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nio | GUANIDINOBUTYRASE (Pseudomonasaeruginosa) |
PF00491(Arginase) | 5 | HIS A 154ASP A 245THR A 255GLY A 169HIS A 168 | MN A1602 (-3.3A) MN A1602 (-2.2A)NoneNoneNone | 1.30A | 6f3nB-3nioA:undetectable | 6f3nB-3nioA:20.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 62ASP A 139GLU A 205LYS A 235ASP A 239LEU A 395 | ADE A 506 (-4.6A)NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)NAD A 501 (-4.2A) | 1.28A | 6f3nB-3oneA:51.7 | 6f3nB-3oneA:47.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 62THR A 64ASP A 139GLU A 205THR A 206LYS A 235ASP A 239LEU A 398GLY A 403HIS A 404MET A 409PHE A 413 | ADE A 506 (-4.6A)ADE A 506 (-2.8A)NoneNoneNAD A 501 (-2.8A)NAD A 501 ( 4.2A)NAD A 501 ( 4.5A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.4A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.15A | 6f3nB-3oneA:51.7 | 6f3nB-3oneA:47.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 67ASP A 139THR A 206ASP A 239 | ADE A 506 (-4.6A)ADE A 506 (-4.5A)NoneNAD A 501 (-2.8A)NAD A 501 ( 4.5A) | 1.28A | 6f3nB-3oneA:51.7 | 6f3nB-3oneA:47.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qvf | FOMA PROTEIN (Streptomyceswedmorensis) |
PF00696(AA_kinase) | 5 | ASP A 150THR A 215ASP A 208GLY A 54HIS A 58 | MG A5000 (-4.0A)NoneADP A1260 ( 3.9A)FV1 A4001 (-3.2A)FV1 A4001 (-4.0A) | 1.28A | 6f3nB-3qvfA:2.4 | 6f3nB-3qvfA:19.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qvf | FOMA PROTEIN (Streptomyceswedmorensis) |
PF00696(AA_kinase) | 5 | ASP A 150THR A 215ASP A 208GLY A 57HIS A 58 | MG A5000 (-4.0A)NoneADP A1260 ( 3.9A)FV1 A4001 (-3.4A)FV1 A4001 (-4.0A) | 1.27A | 6f3nB-3qvfA:2.4 | 6f3nB-3qvfA:19.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rre | PUTATIVEUNCHARACTERIZEDPROTEIN (Thermotogamaritima) |
PF01256(Carb_kinase)PF03853(YjeF_N) | 5 | THR A 171ASP A 55ASP A 5GLY A 173HIS A 198 | NoneGOL A 496 (-3.1A)GOL A 496 (-2.9A)NoneNone | 1.42A | 6f3nB-3rreA:2.4 | 6f3nB-3rreA:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sl1 | ARGINASE (Plasmodiumfalciparum) |
PF00491(Arginase) | 5 | HIS A 218ASP A 325THR A 335GLY A 234HIS A 233 | MN A 412 ( 3.3A) MN A 412 ( 2.0A)NoneFB6 A 414 (-3.6A)FB6 A 414 (-3.5A) | 1.24A | 6f3nB-3sl1A:undetectable | 6f3nB-3sl1A:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dz4 | AGMATINASE (Burkholderiathailandensis) |
PF00491(Arginase) | 5 | HIS A 161ASP A 244THR A 254GLY A 176HIS A 175 | MN A 401 (-3.4A) MN A 401 (-2.0A)NoneUNK A 409 ( 3.4A)UNK A 407 ( 3.8A) | 1.28A | 6f3nB-4dz4A:2.2 | 6f3nB-4dz4A:22.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4efz | METALLO-BETA-LACTAMASE FAMILY PROTEIN (Burkholderiapseudomallei) |
PF00753(Lactamase_B) | 5 | HIS A 73THR A 11ASP A 30THR A 67ASP A 170 | NoneNoneNoneNone CA A 301 (-3.3A) | 1.49A | 6f3nB-4efzA:undetectable | 6f3nB-4efzA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hxq | ARGINASE-1 (Homo sapiens) |
PF00491(Arginase) | 5 | HIS A 126ASP A 234THR A 244GLY A 142HIS A 141 | MN A 902 ( 3.4A) MN A 902 ( 2.0A)NoneX8A A 901 ( 3.7A)X8A A 901 (-3.4A) | 1.32A | 6f3nB-4hxqA:2.5 | 6f3nB-4hxqA:21.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iu4 | ARGINASE (Leishmaniamexicana) |
PF00491(Arginase) | 5 | HIS A 139ASP A 245THR A 255GLY A 155HIS A 154 | MN A 402 ( 3.4A) MN A 402 ( 2.0A)NoneS2C A 405 ( 3.7A)S2C A 405 (-3.2A) | 1.31A | 6f3nB-4iu4A:undetectable | 6f3nB-4iu4A:22.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ixu | ARGINASE-2,MITOCHONDRIAL (Homo sapiens) |
PF00491(Arginase) | 5 | HIS A 145ASP A 253THR A 263GLY A 161HIS A 160 | MN A 402 ( 3.3A) MN A 402 ( 2.0A)None38I A 406 ( 3.7A)38I A 406 (-3.5A) | 1.26A | 6f3nB-4ixuA:2.6 | 6f3nB-4ixuA:20.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | GLU A 197THR A 198GLY A 235MET A 397PHE A 401 | ADN A 501 (-3.6A)NAD A 503 ( 2.9A)NoneADN A 501 (-3.7A)ADN A 501 (-4.8A) | 1.49A | 6f3nB-4lvcA:53.6 | 6f3nB-4lvcA:52.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 58ASP A 135GLU A 197LYS A 227ASP A 231LEU A 383HIS A 392 | ADN A 501 (-4.0A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)NAD A 503 ( 3.9A)ADN A 501 (-3.5A) | 1.45A | 6f3nB-4lvcA:53.6 | 6f3nB-4lvcA:52.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 58THR A 60ASP A 135GLU A 197THR A 198LYS A 227ASP A 231LEU A 386GLY A 391HIS A 392MET A 397PHE A 401 | ADN A 501 (-4.0A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)NAD A 503 ( 2.9A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-3.5A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.22A | 6f3nB-4lvcA:53.6 | 6f3nB-4lvcA:52.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 135THR A 198ASP A 231 | ADN A 501 (-4.0A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)NAD A 503 ( 2.9A)ADN A 501 (-3.1A) | 1.26A | 6f3nB-4lvcA:53.6 | 6f3nB-4lvcA:52.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mo9 | PERIPLASMIC BINDINGPROTEIN (Veillonellaparvula) |
PF01497(Peripla_BP_2) | 5 | ASP A 77LEU A 314GLY A 313MET A 78PHE A 82 | None | 1.39A | 6f3nB-4mo9A:undetectable | 6f3nB-4mo9A:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q3r | ARGINASE (Schistosomamansoni) |
PF00491(Arginase) | 5 | HIS A 156ASP A 264THR A 274GLY A 172HIS A 171 | MN A 402 ( 3.3A) MN A 402 ( 2.1A)NoneXA2 A 407 ( 3.8A)XA2 A 407 (-3.2A) | 1.34A | 6f3nB-4q3rA:2.1 | 6f3nB-4q3rA:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gt2 | PROBABLEDEFERROCHELATASE/PEROXIDASE YFEX (Escherichiacoli) |
PF04261(Dyp_perox) | 5 | THR A 282ASP A 276HIS A 216MET A 266PHE A 268 | HEM A 401 ( 3.6A)NoneHEM A 401 (-3.5A)HEM A 401 (-3.6A)None | 1.33A | 6f3nB-5gt2A:undetectable | 6f3nB-5gt2A:19.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5htv | PUTATIVE XYLULOSEKINASE (Arabidopsisthaliana) |
PF00370(FGGY_N)PF02782(FGGY_C) | 5 | THR A 234THR A 247ASP A 283LEU A 425GLY A 208 | None | 1.12A | 6f3nB-5htvA:undetectable | 6f3nB-5htvA:22.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | HIS A 53ASP A 137GLU A 211THR A 212LYS A 241ASP A 245LEU A 401HIS A 410 | SAH A 502 (-4.0A)SAH A 502 (-3.4A)SAH A 502 (-3.8A)NAD A 501 ( 4.1A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)NAD A 501 (-4.1A)SAH A 502 ( 3.5A) | 1.43A | 6f3nB-5utuA:49.5 | 6f3nB-5utuA:42.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 53THR A 55ASP A 137GLU A 211THR A 212LYS A 241ASP A 245LEU A 404GLY A 409HIS A 410MET A 415PHE A 419 | SAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-3.4A)SAH A 502 (-3.8A)NAD A 501 ( 4.1A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)SAH A 502 ( 4.7A)SAH A 502 ( 3.7A)SAH A 502 ( 3.5A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.35A | 6f3nB-5utuA:49.5 | 6f3nB-5utuA:42.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 53THR A 58ASP A 137THR A 212ASP A 245 | SAH A 502 (-4.0A)SAH A 502 (-4.2A)SAH A 502 (-3.4A)NAD A 501 ( 4.1A)SAH A 502 (-2.8A) | 1.43A | 6f3nB-5utuA:49.5 | 6f3nB-5utuA:42.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | GLU A 197THR A 198GLY A 235MET A 400PHE A 404 | ADN A 502 (-3.5A)NAD A 501 ( 2.9A)NoneADN A 502 (-3.8A)ADN A 502 (-4.9A) | 1.46A | 6f3nB-5v96A:52.9 | 6f3nB-5v96A:46.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 59ASP A 136GLU A 197LYS A 227ASP A 231LEU A 386HIS A 395 | ADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-3.5A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)NAD A 501 (-3.9A)ADN A 502 ( 3.4A) | 1.46A | 6f3nB-5v96A:52.9 | 6f3nB-5v96A:46.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 59THR A 61ASP A 136GLU A 197THR A 198LYS A 227ASP A 231LEU A 389GLY A 394HIS A 395MET A 400PHE A 404 | ADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-2.9A)ADN A 502 (-3.5A)NAD A 501 ( 2.9A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 ( 4.7A)ADN A 502 (-3.7A)ADN A 502 ( 3.4A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.18A | 6f3nB-5v96A:52.9 | 6f3nB-5v96A:46.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 59THR A 64ASP A 136THR A 198ASP A 231 | ADN A 502 ( 3.9A)ADN A 502 (-4.4A)ADN A 502 (-2.9A)NAD A 501 ( 2.9A)ADN A 502 (-2.8A) | 1.23A | 6f3nB-5v96A:52.9 | 6f3nB-5v96A:46.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 131LYS A 186ASP A 190HIS A 353PHE A 362 | NoneNoneNAD A 501 (-4.1A)NAD A 501 (-4.5A)None | 0.98A | 6f3nB-5w4bA:47.1 | 6f3nB-5w4bA:56.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 131LYS A 186HIS A 353MET A 358PHE A 362 | NoneNoneNAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.76A | 6f3nB-5w4bA:47.1 | 6f3nB-5w4bA:56.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | HIS A 55THR A 57ASP A 131GLU A 156THR A 157LYS A 186MET A 358PHE A 362 | 9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNoneNone9W4 A 502 (-3.6A)None | 0.73A | 6f3nB-5w4bA:47.1 | 6f3nB-5w4bA:56.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 55THR A 57ASP A 131THR A 157LYS A 186ASP A 190PHE A 362 | 9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNoneNAD A 501 (-4.1A)None | 0.80A | 6f3nB-5w4bA:47.1 | 6f3nB-5w4bA:56.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 55THR A 60ASP A 131THR A 157ASP A 190 | 9W4 A 502 (-3.7A)NoneNoneNoneNAD A 501 (-4.1A) | 1.44A | 6f3nB-5w4bA:47.1 | 6f3nB-5w4bA:56.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186ASP A 190GLY A 352HIS A 353PHE A 362 | NoneNAD A 501 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)None | 0.91A | 6f3nB-5w4bA:47.1 | 6f3nB-5w4bA:56.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186ASP A 190LEU A 347GLY A 352HIS A 353 | NoneNAD A 501 (-4.1A)9W4 A 502 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A) | 0.91A | 6f3nB-5w4bA:47.1 | 6f3nB-5w4bA:56.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186GLY A 352HIS A 353MET A 358PHE A 362 | None9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.71A | 6f3nB-5w4bA:47.1 | 6f3nB-5w4bA:56.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186LEU A 347GLY A 352HIS A 353MET A 358 | None9W4 A 502 (-4.1A)9W4 A 502 ( 3.9A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A) | 0.68A | 6f3nB-5w4bA:47.1 | 6f3nB-5w4bA:56.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xn8 | GLYCEROLDEHYDROGENASE (unidentified) |
PF00465(Fe-ADH) | 5 | HIS A 254ASP A 171THR A 120LEU A 250GLY A 249 | ZN A 401 (-3.4A) ZN A 401 (-2.3A)NoneNoneNone | 1.24A | 6f3nB-5xn8A:3.7 | 6f3nB-5xn8A:22.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | ASP A 136GLU A 161THR A 162LYS A 191ASP A 195LEU A 349HIS A 358 | ADN A 501 (-3.0A)ADN A 501 (-2.5A)NAD A 500 ( 2.9A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)NAD A 500 ( 4.3A)ADN A 501 ( 3.5A) | 1.40A | 6f3nB-6aphA:58.4 | 6f3nB-6aphA:56.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | HIS A 58THR A 60ASP A 136GLU A 161THR A 162LYS A 191ASP A 195LEU A 352GLY A 357HIS A 358MET A 363PHE A 367 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-2.5A)NAD A 500 ( 2.9A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 ( 3.5A)ADN A 501 (-3.7A)None | 0.52A | 6f3nB-6aphA:58.4 | 6f3nB-6aphA:56.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58THR A 63ASP A 136THR A 162ASP A 195 | ADN A 501 (-3.9A)ADN A 501 (-4.5A)ADN A 501 (-3.0A)NAD A 500 ( 2.9A)ADN A 501 (-2.7A) | 1.25A | 6f3nB-6aphA:58.4 | 6f3nB-6aphA:56.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6btm | ALTERNATIVE COMPLEXIII SUBUNIT B (Flavobacteriumjohnsoniae) |
no annotation | 5 | ASP B 580THR B 583LEU B 288GLY B 765PHE B 578 | None | 1.41A | 6f3nB-6btmB:undetectable | 6f3nB-6btmB:10.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 7 | HIS B 61ASP B 139GLU B 164LYS B 194ASP B 198LEU B 373HIS B 382 | ADN B 502 ( 4.0A) ZN B 505 ( 2.5A)ADN B 502 (-3.6A)ADN B 502 (-2.8A)ADN B 502 (-2.7A)NAD B 501 ( 3.9A)ADN B 502 (-3.4A) | 1.40A | 6f3nB-6f3mB:65.4 | 6f3nB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 12 | HIS B 61THR B 63ASP B 139GLU B 164THR B 165LYS B 194ASP B 198LEU B 376GLY B 381HIS B 382MET B 387PHE B 391 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) ZN B 505 ( 2.5A)ADN B 502 (-3.6A)NAD B 501 ( 2.8A)ADN B 502 (-2.8A)ADN B 502 (-2.7A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.4A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.11A | 6f3nB-6f3mB:65.4 | 6f3nB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 5 | HIS B 61THR B 66ASP B 139THR B 165ASP B 198 | ADN B 502 ( 4.0A)ADN B 502 (-4.6A) ZN B 505 ( 2.5A)NAD B 501 ( 2.8A)ADN B 502 (-2.7A) | 1.29A | 6f3nB-6f3mB:65.4 | 6f3nB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fks | - (-) |
no annotation | 5 | THR A 280ASP A 274HIS A 215MET A 265PHE A 266 | HEM A 301 (-3.0A)NoneHEM A 301 (-3.3A)HEM A 301 (-3.1A)None | 1.33A | 6f3nB-6fksA:undetectable | 6f3nB-6fksA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 5 | GLU A 159THR A 160GLY A 197MET A 361PHE A 365 | ADN A 501 (-3.9A)NAD A 502 ( 2.8A)NoneADN A 501 (-3.6A)None | 1.48A | 6f3nB-6gbnA:57.7 | 6f3nB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 7 | HIS A 56ASP A 134GLU A 159LYS A 189ASP A 193LEU A 347HIS A 356 | ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)NAD A 502 (-3.9A)ADN A 501 (-3.4A) | 1.43A | 6f3nB-6gbnA:57.7 | 6f3nB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 12 | HIS A 56THR A 58ASP A 134GLU A 159THR A 160LYS A 189ASP A 193LEU A 350GLY A 355HIS A 356MET A 361PHE A 365 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-2.9A)ADN A 501 (-3.9A)NAD A 502 ( 2.8A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.4A)ADN A 501 (-3.6A)None | 0.20A | 6f3nB-6gbnA:57.7 | 6f3nB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 5 | HIS A 56THR A 61ASP A 134THR A 160ASP A 193 | ADN A 501 (-3.9A)ADN A 501 (-4.6A)ADN A 501 (-2.9A)NAD A 502 ( 2.8A)ADN A 501 (-2.7A) | 1.23A | 6f3nB-6gbnA:57.7 | 6f3nB-6gbnA:undetectable |